Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia

Social Science and Medicine

Volumn 63, Issue 7, 2006, Pages 1947-1959

  Saukko, Paula M ^a   Richards, Suzanne H ^a   Shepherd, Maggie H ^b   Campbell, John L ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Deep vein thrombosis; Genetic risk; Genetic testing; Patient perceptions; Thrombophilia; UK

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

BLOOD SYSTEM DISORDER; CANCER; DIABETES; GENETIC ANALYSIS; PARTICIPATORY APPROACH; QUALITATIVE ANALYSIS;

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CARDIOVASCULAR RISK; CONFUSION; CONTROLLED STUDY; DECISION MAKING; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DIAGNOSTIC TEST; FEMALE; GENETIC COUNSELING; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEALTH; HIGH RISK PATIENT; HORMONE SUBSTITUTION; HUMAN; LIFE; LIFESTYLE; MALE; MEDICAL INFORMATION; QUALITATIVE RESEARCH; RISK REDUCTION; SCIENCE; SEMI STRUCTURED INTERVIEW; SOCIAL PROBLEM; SOCIAL SUPPORT; SOCIOECONOMICS; THROMBOPHILIA; UNITED KINGDOM;

ADULT; ENGLAND; FAMILY PLANNING SERVICES; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC TESTING; HUMANS; INTERVIEWS; INTERVIEWS AS TOPIC; MALE; RISK FACTORS; THROMBOPHILIA;

EURASIA; EUROPE; UNITED KINGDOM; WESTERN EUROPE;

EID: 33746782221     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2006.04.012     Document Type: Article

References (43)

1. Annas G.J., Glantz L.H., and Roche P.A. Drafting the genetic privacy act: Science, policy and practical considerations. Journal of Law, Medicine and Ethics 23 (1995) 360-366
2. Bharadwaj A. Uncertain risk: Genetic screening for susceptibility to haemochromatosis. Health, Risk and Society 4 3 (2002) 227-240
3. Bharadwaj, A., Prior, L., Atkinson, P., Clarke, A., & Worwood, M. (in press). The genetic iceberg: Risk and uncertainty in cancer genetics and haemochromatosis. In A. Webster (Ed.), Innovative health technologies: Meaning, context and change. London: Palgrave/Macmillan.
4. Broadstock M., Michie S., and Marteau T. Psychological consequences of predictive genetic testing: A systematic review. European Journal of Human Genetics 8 (2000) 731-738
5. Clarke A.J. The process of genetic counseling: Beyond non-directiveness. In: Harper P., and Clarke A. (Eds). Genetics, society and clinical practice (1997), Bios Scientific Publishers, Oxford 179-200
6. Department of Health. (2003). Our inheritance, our future: Realising the potential of genetics in the NHS. London: The Stationary Office.
7. Everett M. Can you keep a genetic secret? The genetic privacy movement. Journal of Genetic Counselling 13 4 (2004) 273-291
8. Green M.J., and Botkin J.R. "Genetic exceptionalism" in medicine: Clarifying the differences between genetic and nongenetic tests. Annals of Internal Medicine 138 (2003) 571-575
9. Grody W., Griffin J., Taylor A., Korf B., and Hiet J. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genetics in Medicine 3 2 (2001) 139-148
10. Haga S., Khoury M., and Burke W. Genomic profiling to promote healthy lifestyle: Not ready for prime time. Nature Genetics 34 4 (2003) 347-350
11. Hallowell N. Varieties of suffering: Living with the risk of ovarian cancer. Health, Risk and Society 8 1 (2006) 9-26
12. Hallowell N., Foster C., Eeles R., Ardern-Jones A., and Watson M. Accommodating risk: Responses to BRCA 1/2 genetic testing of women who have had cancer. Social Science and Medicine 59 3 (2004) 533-565
13. Hellmann E.A., Leslie N.D., and Moll S. Knowledge and educational needs of individuals with the factor V Leiden mutation. Journal of Thrombosis and Haemostasis 1 11 (2003) 2335-2339
14. Human Genetics Commission. (2002). Inside information: Balancing interests in the use of personal genetic data. A Report.
15. Hunt K., Emslie C., and Watt G. Lay constructions of a family history of heart disease: Potential for misunderstandings in the clinical encounter. Lancet 357 (2001) 1168-1171
16. Lerman C., Gold K., Audrain J., Lin T.H., Boyd N.R., Orleans C.T., et al. Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: Effects on smoking-related cognitions, emotions and behaviour. Health Psychology 16 1 (1997) 87-99
17. Lippman, A. (1998). The politics of health: Geneticization versus health promotion. In The politics of women's health: Exploring agency and autonomy (pp. 64-82). Philadelphia: Temple University Press.
18. Marteau T., and Lerman C. Genetic risk and behavioural change. British Medical Journal 322 (2001) 1056-1059
19. Marteau T., and Weinman J. Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research. Social Science and Medicine 62 6 (2006) 1360-1368
20. McBride C., Bepler G., Lipkus I., Lyna P., Samsa G., Albright J., et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiology Biomarkers and Prevention 11 (2002) 521-528
21. Meiser B., Dunn S., Dixon J., and Powell L.W. Psychological adjustment and knowledge about hereditary hemochromatosis in a clinic-based sample: A prospective study. Journal of Genetic Counselling 30 (2005)
22. Melzer D., and Zimmern R. Genetics and medicalisation. British Journal of Medicine 324 7324 (2002) 863-864
23. Middeldorp S., Meinardi J., Koopman M., Van Pampus E., Hamulyak K., van der Meer J., et al. A prospective study of asymptomatic carriers of the Factor V Leiden mutation to determine the incidence of venous thromboembolism. Annals of Internal Medicine 135 5 (2001) 322-327
24. Murray T. Genetic exceptionalism and "future diaries": Is genetic information different form other medical information. In: Rothstein M. (Ed). Genetic secrets: Protecting privacy and confidentiality in the genetic era (1997), Yale University Press, New Heaven, CO 60-73
25. National Statistics. (1990). Standard occupational classification. Available at: 〈http://www.statistics.gov.uk/methods_quality/ns_sec/soc2000.asp〉.
26. NHS Modernization Agency. (2001). Discovery interviews. Available at: 〈http://www.modern.nhs.uk/improvementguides/patients/5_5.html〉.
27. Novas C., and Rose N. Genetic risks and the birth of the somatic individual. Economy and Society 29 4 (2000) 485-513
28. Petersen A. The best experts: The narratives of those who have a genetic condition. Social Science and Medicine 63 1 (2006) 32-42
29. Petersen A., and Bunton R. The new genetics and the public's health (2002), Routledge, London
30. Prandoni P., Lensing A.W., Cogo A., Cuppini S., Villalta S., Carta M., et al. The long-term clinical course of acute deep venous thrombosis. Annals of Internal Medicine 125 (1996) 1-7
31. Ross L.F. Genetic exceptionalism vs. paradigm shift: Lessons from HIV. Journal of Law, Medicine and Ethics 29 (2001) 141-148
32. Rothstein M. Genetic exceptionalism and legislative pragmatism. Hasting Center Report 35 4 (2005) 27-33
33. Saukko, P., Ellard, S., Richards, S., Shepherd, M. (submitted). Patient experiences of genetic testing in mainstream primary and secondary care: A qualitative study on thrombophilia.
34. Secretary's Advisory Committee on Genetic Testing (SACGT). (2001). Development of a classification methodology for genetic tests. Bethesda. Available at: 〈http://www4.od.nih.gov/oba/sacgt.htm〉.
35. Senior V., Marteau T., and Peters T. Will genetic testing for predisposition for disease result in fatalism? A qualitative study of parents responses to neonatal screening for familial hypercholesterolaemia. Social Science and Medicine 48 12 (1999) 1857-1860
36. Senior V., Smith J., Michie S., and Marteau T. Making sense of risk: An interpretative phenomenological analysis to vulnerability to heart disease. Journal of Health Psychology 7 2 (2002) 157-168
37. Skirton H. The client's perspective of genetic counseling-A grounded theory study. Journal of Genetic Counselling 10 5 (2001) 311-329
38. Smith J., Michie S., Stephenson M., and Quarrel O. Risk perception and decision-making in candidates for genetic testing for Huntington's disease: An interpretative phenomenological analysis. Journal of Health Psychology 7 2 (2002) 131-144
39. UK Genetic Testing Network. (2003). A list of tests offered by the UK GTN laboratories. UK Genetic Testing Network, available at: 〈http://www.ukgtn.org/directory.html〉.
40. Walker I., Greaves M., and Preston F. Guideline: Investigation and management of heritable thrombophilia. British Journal of Haematology 114 (2001) 512-528
41. Walter F., and Emery J. "Coming down the line": Patients' understanding of their family history of common chronic diseases. Annals of Family Medicine 3 5 (2005) 405-414
42. Walter F., Emery J., Braithwaite D., and Marteau T. Lay understanding of familial risk of common chronic diseases: A systematic review and synthesis of qualitative research. Annals of Family Medicine 2 6 (2004) 583-594
43. Watkins H., and Farrall M. Genetic susceptibility to coronary artery disease: From promise to progress. Nature Reviews Genetics 7 3 (2006) 163-173